Eurofarma

Lula reelection campaign and Meta interference allegations

4 clusters · 56 sources · last updated about 18 hours ago

Latest: Lula da Silva campaign accuses Meta of interfering in Brazilian elections

President Luiz Inácio Lula da Silva’s reelection campaign in Brazil has transitioned from large-scale political rallies to more cost-effective walking tours. During a visit to Montes Claros, Minas Gerais, Lula campaigned

GLP-1 drugs: clinical trends, safety, and market shifts

291 clusters · 1104 sources · last updated 1 day ago

Latest: Novo Nordisk faces lawsuits over Ozempic and NAION risks

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

Brazil plans semaglutide integration into SUS

8 clusters · 117 sources · last updated 8 days ago

Latest: GLP-1 weight loss drug prescriptions surge 304.9% in Brazil

The Brazilian Ministry of Health is progressing with plans to incorporate semaglutide-based weight-loss medications into the Unified Health System (SUS). On September 24, 2026, the Ministry submitted a formal request to

Global medicinal cannabis market expansion

3 clusters · 6 sources · last updated 24 days ago

Latest: Industrial innovation in Brazil and cannabis exports in Portugal

Global medicinal cannabis markets are experiencing growth and regulatory shifts across several regions. In Portugal, medicinal cannabis exports have seen massive growth. Official reports from Infarmed show that the coun

Semaglutide regulatory approvals and pricing in Brazil

8 clusters · 112 sources · last updated 28 days ago

Latest: Brazil expands access to obesity and diabetes treatments

Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject